Follow
MASAUD SHAH
Title
Cited by
Cited by
Year
Recent clinical trends in Toll‐like receptor targeting therapeutics
MA Anwar, M Shah, J Kim, S Choi
Medicinal research reviews 39 (3), 1053-1090, 2019
2422019
Omicron: a heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escapes approved COVID-19 therapeutic antibodies
M Shah, HG Woo
Frontiers in immunology 12, 830527, 2022
1932022
Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control
P Durai, M Batool, M Shah, S Choi
Experimental & molecular medicine 47 (8), e181-e181, 2015
1422015
Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization
M Shah, B Ahmad, S Choi, HG Woo
Computational and Structural Biotechnology Journal 18, 3402-3414, 2020
722020
Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases
MC Patra, M Shah, S Choi
Seminars in cancer biology 64, 61-82, 2020
702020
Insights into the species-specific TLR4 signaling mechanism in response to Rhodobacter sphaeroides lipid A detection
MA Anwar, S Panneerselvam, M Shah, S Choi
Scientific Reports 5 (1), 7657, 2015
542015
Resistance of polio to its eradication in Pakistan
M Shah, MK Khan, S Shakeel, F Mahmood, Z Sher, MB Sarwar, A Sumrin
Virology journal 8, 1-6, 2011
502011
TLR4/MD2 specific peptides stalled in vivo LPS-induced immune exacerbation
S Park, HJ Shin, M Shah, HY Cho, MA Anwar, A Achek, HK Kwon, B Lee, ...
Biomaterials 126, 49-60, 2017
472017
A situational analysis of HIV and AIDS in Pakistan
M Ilyas, S Asad, L Ali, M Shah, S Badar, MT Sarwar, A Sumrin
Virology journal 8, 1-3, 2011
442011
In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response
M Shah, MA Anwar, S Park, SS Jafri, S Choi
Scientific reports 5 (1), 13446, 2015
412015
Molecular docking study of P4-Benzoxaborolesubstituted ligands as inhibitors of HCV NS3/4A protease
A Wadood, M Riaz, SB Jamal, M Shah, MA Lodhi
Bioinformation 9 (6), 309, 2013
382013
A structural insight into the negative effects of opioids in analgesia by modulating the TLR4 signaling: An in silico approach
M Shah, MA Anwar, D Yesudhas, J Krishnan, S Choi
Scientific reports 6 (1), 39271, 2016
372016
In-silico design of peptide inhibitors of K-Ras target in cancer disease
M Ghufran, AU Rehman, M Shah, M Ayaz, HL Ng, A Wadood
Journal of Biomolecular Structure and Dynamics 38 (18), 5488-5499, 2020
352020
Oceans as a source of immunotherapy
B Ahmad, M Shah, S Choi
Marine drugs 17 (5), 282, 2019
332019
Screening and design of anti-diabetic compounds sourced from the leaves of neem (Azadirachta indica)
A Jalil, UA Ashfaq, S Shahzadi, MR Javed, I Rasul, S Rehman, M Shah, ...
Bioinformation 9 (20), 1031, 2013
332013
Linear and rationally designed stapled peptides abrogate TLR4 pathway and relieve inflammatory symptoms in rheumatoid arthritis rat model
A Achek, M Shah, JY Seo, HK Kwon, X Gui, HJ Shin, EY Cho, BS Lee, ...
Journal of medicinal chemistry 62 (14), 6495-6511, 2019
312019
Advances in antiviral therapies targeting toll-like receptors
M Shah, MA Anwar, JH Kim, S Choi
Expert opinion on investigational drugs 25 (4), 437-453, 2016
312016
Structural insight into the Middle East respiratory syndrome coronavirus 4a protein and dsRNA binding mechanism
B Maria, S Masaud, P Mahesh, Chandra, Y Dhanusha, C and Sangdun
Scientific reports, 2017
302017
Structural-dynamic insights into the H. pylori cytotoxin-associated gene A (CagA) and its abrogation to interact with the tumor suppressor protein ASPP2 using decoy peptides
M Junaid, M Shah, A Khan, CD Li, MT Khan, AC Kaushik, A Ali, ...
Journal of Biomolecular Structure and Dynamics, 2018
282018
Interaction and inhibition of dengue envelope glycoprotein with mammalian receptor DC-sign, an in-silico approach
M Shah, A Wadood, Z Rahman, T Husnain
PLoS One 8 (3), e59211, 2013
282013
The system can't perform the operation now. Try again later.
Articles 1–20